µÚËÄÕ ֬ÖʺÍÖ¬µ°°×´úлÎÉÂÒµÄÉúÎﻯѧ¼ìÑé ÏÂÔر¾ÎÄ

?ËÄ¡¢¸ßÃܶÈÖ¬µ°°×µÄ¿¹¶¯ÂöÖàÑùÓ²»¯¹¦ÄÜÖ÷Òª»úÖÆΪ£º¶ÔLDLÑõ»¯ÒÖÖÆÖкÍÐÞÊÎLDLÅä»ù»îÐÔÒÖÖÆÄÚƤϸ°ûÕ³¸½·Ö×ӵıí´ï?Îå¡¢´úл×ÛºÏÕ÷£¨metabolic syndrome£¬MS£©

?MSÊÇÒ»×鸴ÔӵĴúлÎÉÂÒÖ¢ºòȺ£¬°üÀ¨ÖÐÐÄÐÔ·ÊÅÖ¡¢TGˮƽÉý¸ß¡¢HDL-C¼õµÍ¡¢¸ßѪѹ¡¢¿Õ¸¹ÑªÌÇÉý¸ß£¬Êǵ¼ÖÂÌÇÄò²¡(DM)ºÍÐÄÄÔѪ¹Ü¼²²¡(CVD)µÄΣÏÕÒòËØ¡£

?2005Ä꣬IDF×ÛºÏÁËÀ´×ÔÊÀ½çÁù´óÖÞÌÇÄò²¡Ñ§¡¢ÐÄѪ¹Ü²¡Ñ§¡¢ÑªÖ¬

ѧ¡¢¹«¹²ÎÀÉú¡¢Á÷Ðв¡Ñ§¡¢ÒÅ´«Ñ§¡¢ÓªÑøºÍ´úлѧר¼ÒµÄÒâ¼û£¬°ä²¼ÁË´úл×ÛºÏÕ÷µÄ¶¨Ò壬ºÍÒÔÍùÇø±ðµÄÊǴ˴δúл×ÛºÏÕ÷µÄ¶¨ÒåÇ¿µ÷ÒÔÖÐÐÄÐÔ·ÊÅÖΪºËÐÄ£¬²ÉÄÉÑüΧ×÷ΪÕï¶ÏÖ¸±ê¡£ÆäÖÐÖÐÐÄÐÔ·ÊÅÖΪ±ØÐ룬¼ÓÉϸÊÓÍÈýõ¥£¨TG£©Éý¸ß¡¢HDL-C¼õµÍ¡¢ÑªÑ¹Éý¸ß¡¢¿Õ¸¹ÑªÌÇ£¨FPG£©Éý¸ß»òÒÑÕï¶ÏΪ2ÐÍÌÇÄò²¡£¨T2DM£©ËÄÏîÖеÄÈÎÒâÁ½Ïî¡£

Panel:International Diabetes Federation: metabolic syndrome de?nition (2005)?Central obesity?Waist circumference*¡ªethnicity speci?c (see table below)?Plus any two:?Raised triglycerides?>150 mg/dL (1.7 mmol/L)?Speci?c treatment for this lipid abnormality?Reduced HDL-cholesterol?<40 mg/dL (1.03 mmol/L) in men?<50 mg/dL (1.29 mmol/L) in women?Speci?c treatment for this lipid abnormality?Raised blood pressure?Systolic¡Ý130 mm Hg?Diastolic¡Ý85 mm Hg?Treatment of previously diagnosed hypertension?Raised fasting plasma glucose??Fasting plasma glucose 100 mg/dL (5.6 mmol/L)?Previously diagnosed type 2 diabetesEthnic-speci?c values for waist circumference

Ethnic groupEuropids*MenWomenSouth AsiansMenWomenWaist circumference (as measure of central obesity)¡Ý94 cm¡Ý80 cm¡Ý90 cm¡Ý80 cmChineseMenWomenJapaneseMenWomenEthnic south and central AmericansSub-Saharan AfricansEastern Mediterranean and middle east (Arab) populations ¡Ý90 cm¡Ý80 cm¡Ý85cm¡Ý90 cmUse south Asian recommendations until more speci?c data are availableUse European data until more speci?c data are availableUse European data until more speci?c data are available